Annual Net Income
$18.78 M
+$66.67 M+139.21%
31 December 2023
Summary:
ANI Pharmaceuticals annual net profit is currently $18.78 million, with the most recent change of +$66.67 million (+139.21%) on 31 December 2023. During the last 3 years, it has risen by +$41.33 million (+183.28%). ANIP annual net income is now -34.67% below its all-time high of $28.75 million, reached on 31 December 2014.ANIP Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$24.17 M
-$21.88 M-956.67%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly net profit is currently -$24.17 million, with the most recent change of -$21.88 million (-956.67%) on 30 September 2024. Over the past year, it has dropped by -$34.11 million (-343.12%). ANIP quarterly net income is now -215.05% below its all-time high of $21.00 million, reached on 31 December 2014.ANIP Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$7.09 M
-$34.11 M-126.25%
30 September 2024
Summary:
ANI Pharmaceuticals TTM net profit is currently -$7.09 million, with the most recent change of -$34.11 million (-126.25%) on 30 September 2024. Over the past year, it has dropped by -$20.47 million (-152.99%). ANIP TTM net income is now -119.87% below its all-time high of $35.69 million, reached on 30 June 2015.ANIP TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +139.2% | -343.1% | -153.0% |
| 3 y3 years | +183.3% | -443.4% | +67.9% |
| 5 y5 years | +21.2% | -720.4% | -143.3% |
ANIP Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +139.2% | -232.7% | at low | -120.0% | +89.5% |
| 5 y | 5 years | at high | +139.2% | -232.7% | at low | -120.0% | +89.5% |
| alltime | all time | -34.7% | +136.4% | -215.1% | +25.6% | -119.9% | +89.5% |
ANI Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.17 M(+956.7%) | -$7.09 M(-126.2%) |
| June 2024 | - | -$2.29 M(-112.6%) | $27.02 M(-24.0%) |
| Mar 2024 | - | $18.21 M(+1476.4%) | $35.55 M(+89.3%) |
| Dec 2023 | $18.78 M(-139.2%) | $1.16 M(-88.4%) | $18.78 M(+40.3%) |
| Sept 2023 | - | $9.94 M(+59.2%) | $13.38 M(-359.4%) |
| June 2023 | - | $6.25 M(+334.0%) | -$5.16 M(-80.4%) |
| Mar 2023 | - | $1.44 M(-133.9%) | -$26.33 M(-45.0%) |
| Dec 2022 | -$47.90 M(+12.4%) | -$4.24 M(-50.7%) | -$47.90 M(-29.3%) |
| Sept 2022 | - | -$8.60 M(-42.4%) | -$67.79 M(+6.5%) |
| June 2022 | - | -$14.92 M(-25.9%) | -$63.64 M(+1.3%) |
| Mar 2022 | - | -$20.13 M(-16.6%) | -$62.82 M(+47.5%) |
| Dec 2021 | -$42.60 M(+88.9%) | -$24.14 M(+442.7%) | -$42.60 M(+92.8%) |
| Sept 2021 | - | -$4.45 M(-68.5%) | -$22.10 M(+28.3%) |
| June 2021 | - | -$14.11 M(<-9900.0%) | -$17.22 M(+11.5%) |
| Mar 2021 | - | $86.00 K(-102.4%) | -$15.45 M(-31.5%) |
| Dec 2020 | -$22.55 M(-470.0%) | -$3.63 M(-937.6%) | -$22.55 M(-5.1%) |
| Sept 2020 | - | $434.00 K(-103.5%) | -$23.75 M(+17.1%) |
| June 2020 | - | -$12.34 M(+76.0%) | -$20.29 M(+1385.1%) |
| Mar 2020 | - | -$7.01 M(+45.0%) | -$1.37 M(-122.4%) |
| Dec 2019 | $6.09 M(-60.7%) | -$4.83 M(-224.1%) | $6.09 M(-62.7%) |
| Sept 2019 | - | $3.90 M(-40.9%) | $16.36 M(-6.5%) |
| June 2019 | - | $6.58 M(+1366.6%) | $17.50 M(+27.8%) |
| Mar 2019 | - | $449.00 K(-91.7%) | $13.69 M(-11.6%) |
| Dec 2018 | $15.49 M(-1540.0%) | $5.43 M(+7.8%) | $15.49 M(+3461.8%) |
| Sept 2018 | - | $5.04 M(+81.4%) | $435.00 K(+268.6%) |
| June 2018 | - | $2.78 M(+23.4%) | $118.00 K(+436.4%) |
| Mar 2018 | - | $2.25 M(-123.4%) | $22.00 K(-102.0%) |
| Dec 2017 | -$1.08 M(-127.4%) | -$9.63 M(-304.0%) | -$1.08 M(-114.4%) |
| Sept 2017 | - | $4.72 M(+76.1%) | $7.47 M(+41.1%) |
| June 2017 | - | $2.68 M(+132.7%) | $5.30 M(+41.6%) |
| Mar 2017 | - | $1.15 M(-206.7%) | $3.74 M(-4.9%) |
| Dec 2016 | $3.93 M(-74.4%) | -$1.08 M(-142.5%) | $3.93 M(-50.1%) |
| Sept 2016 | - | $2.54 M(+126.0%) | $7.89 M(-20.4%) |
| June 2016 | - | $1.13 M(-16.4%) | $9.91 M(-19.8%) |
| Mar 2016 | - | $1.35 M(-53.2%) | $12.35 M(-19.7%) |
| Dec 2015 | $15.38 M(-46.5%) | $2.88 M(-36.9%) | $15.38 M(-54.1%) |
| Sept 2015 | - | $4.56 M(+27.7%) | $33.50 M(-6.1%) |
| June 2015 | - | $3.57 M(-18.3%) | $35.69 M(+19.9%) |
| Mar 2015 | - | $4.37 M(-79.2%) | $29.76 M(+3.5%) |
| Dec 2014 | $28.75 M(+9482.3%) | $21.00 M(+211.4%) | $28.75 M(+157.3%) |
| Sept 2014 | - | $6.75 M(-385.5%) | $11.17 M(+98.9%) |
| June 2014 | - | -$2.36 M(-170.3%) | $5.62 M(+65.3%) |
| Mar 2014 | - | $3.36 M(-2.1%) | $3.40 M(-251.0%) |
| Dec 2013 | $300.00 K(-101.1%) | $3.43 M(+188.2%) | -$2.25 M(-76.7%) |
| Sept 2013 | - | $1.19 M(-126.0%) | -$9.67 M(-43.1%) |
| June 2013 | - | -$4.58 M(+100.1%) | -$16.98 M(-14.0%) |
| Mar 2013 | - | -$2.29 M(-42.6%) | -$19.74 M(-28.8%) |
| Dec 2012 | -$27.72 M(-46.3%) | -$3.99 M(-34.9%) | -$27.72 M(-8.8%) |
| Sept 2012 | - | -$6.12 M(-16.6%) | -$30.38 M(-17.9%) |
| June 2012 | - | -$7.34 M(-28.5%) | -$36.99 M(-17.1%) |
| Mar 2012 | - | -$10.26 M(+54.4%) | -$44.62 M(-13.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$51.61 M(+11.7%) | -$6.65 M(-47.8%) | -$51.61 M(-11.4%) |
| Sept 2011 | - | -$12.73 M(-15.0%) | -$58.23 M(+2.0%) |
| June 2011 | - | -$14.98 M(-13.2%) | -$57.09 M(+7.9%) |
| Mar 2011 | - | -$17.25 M(+30.0%) | -$52.91 M(+14.5%) |
| Dec 2010 | -$46.20 M(-2.8%) | -$13.27 M(+14.5%) | -$46.20 M(-29.4%) |
| Sept 2010 | - | -$11.59 M(+7.4%) | -$65.41 M(+8.7%) |
| June 2010 | - | -$10.79 M(+2.4%) | -$60.19 M(+11.4%) |
| Mar 2010 | - | -$10.54 M(-67.6%) | -$54.02 M(+13.7%) |
| Dec 2009 | -$47.53 M(+172.8%) | -$32.49 M(+409.9%) | -$47.53 M(+193.2%) |
| Sept 2009 | - | -$6.37 M(+37.9%) | -$16.21 M(-1.3%) |
| June 2009 | - | -$4.62 M(+14.1%) | -$16.42 M(-8.0%) |
| Mar 2009 | - | -$4.05 M(+247.6%) | -$17.85 M(+2.4%) |
| Dec 2008 | -$17.43 M(+129.8%) | -$1.17 M(-82.3%) | -$17.43 M(-2.8%) |
| Sept 2008 | - | -$6.59 M(+8.9%) | -$17.93 M(+37.5%) |
| June 2008 | - | -$6.05 M(+66.8%) | -$13.04 M(+38.8%) |
| Mar 2008 | - | -$3.63 M(+116.6%) | -$9.39 M(+23.9%) |
| Dec 2007 | -$7.58 M(-371.7%) | -$1.67 M(-1.1%) | -$7.58 M(-346.3%) |
| Sept 2007 | - | -$1.69 M(-29.5%) | $3.08 M(-23.5%) |
| June 2007 | - | -$2.40 M(+32.1%) | $4.03 M(-4.2%) |
| Mar 2007 | - | -$1.82 M(-120.2%) | $4.20 M(+50.6%) |
| Dec 2006 | $2.79 M(-128.9%) | $8.99 M(-1306.5%) | $2.79 M(-132.3%) |
| Sept 2006 | - | -$745.10 K(-66.5%) | -$8.64 M(-11.4%) |
| June 2006 | - | -$2.22 M(-31.1%) | -$9.75 M(-3.5%) |
| Mar 2006 | - | -$3.23 M(+32.0%) | -$10.11 M(+4.7%) |
| Dec 2005 | -$9.65 M(-19.7%) | -$2.45 M(+32.0%) | -$9.65 M(-14.8%) |
| Sept 2005 | - | -$1.85 M(-28.2%) | -$11.33 M(-8.2%) |
| June 2005 | - | -$2.58 M(-6.8%) | -$12.35 M(+0.1%) |
| Mar 2005 | - | -$2.77 M(-32.9%) | -$12.34 M(+2.7%) |
| Dec 2004 | -$12.02 M(+101.6%) | -$4.13 M(+43.8%) | -$12.02 M(+25.8%) |
| Sept 2004 | - | -$2.87 M(+11.5%) | -$9.55 M(+17.6%) |
| June 2004 | - | -$2.57 M(+5.3%) | -$8.12 M(+13.4%) |
| Mar 2004 | - | -$2.45 M(+47.3%) | -$7.16 M(+20.1%) |
| Dec 2003 | -$5.96 M(+56.4%) | -$1.66 M(+15.3%) | -$5.96 M(+26.5%) |
| Sept 2003 | - | -$1.44 M(-11.0%) | -$4.71 M(+15.7%) |
| June 2003 | - | -$1.62 M(+29.8%) | -$4.07 M(+3.1%) |
| Mar 2003 | - | -$1.24 M(+202.6%) | -$3.95 M(+3.7%) |
| Dec 2002 | -$3.81 M(+45.9%) | -$411.40 K(-48.6%) | -$3.81 M(-20.8%) |
| Sept 2002 | - | -$801.00 K(-46.4%) | -$4.81 M(+31.4%) |
| June 2002 | - | -$1.50 M(+35.6%) | -$3.66 M(+21.0%) |
| Mar 2002 | - | -$1.10 M(-21.9%) | -$3.02 M(+15.8%) |
| Dec 2001 | -$2.61 M(-24.0%) | -$1.41 M(-504.3%) | -$2.61 M(+22.8%) |
| Sept 2001 | - | $349.20 K(-140.7%) | -$2.13 M(-31.3%) |
| June 2001 | - | -$858.90 K(+24.5%) | -$3.10 M(-15.7%) |
| Mar 2001 | - | -$689.90 K(-25.5%) | -$3.67 M(+6.8%) |
| Dec 2000 | -$3.44 M(+144.4%) | -$926.50 K(+49.3%) | -$3.44 M(+36.9%) |
| Sept 2000 | - | -$620.70 K(-56.7%) | -$2.51 M(+32.8%) |
| June 2000 | - | -$1.43 M(+214.7%) | -$1.89 M(+157.1%) |
| Mar 2000 | - | -$455.80 K(+63.1%) | -$735.20 K(+163.1%) |
| Dec 1999 | -$1.41 M(-47.1%) | - | - |
| June 1999 | - | -$279.40 K | -$279.40 K |
| Dec 1998 | -$2.66 M | - | - |
FAQ
- What is ANI Pharmaceuticals annual net profit?
- What is the all time high annual net income for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual net income year-on-year change?
- What is ANI Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly net income year-on-year change?
- What is ANI Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM net income year-on-year change?
What is ANI Pharmaceuticals annual net profit?
The current annual net income of ANIP is $18.78 M
What is the all time high annual net income for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual net profit is $28.75 M
What is ANI Pharmaceuticals annual net income year-on-year change?
Over the past year, ANIP annual net profit has changed by +$66.67 M (+139.21%)
What is ANI Pharmaceuticals quarterly net profit?
The current quarterly net income of ANIP is -$24.17 M
What is the all time high quarterly net income for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly net profit is $21.00 M
What is ANI Pharmaceuticals quarterly net income year-on-year change?
Over the past year, ANIP quarterly net profit has changed by -$34.11 M (-343.12%)
What is ANI Pharmaceuticals TTM net profit?
The current TTM net income of ANIP is -$7.09 M
What is the all time high TTM net income for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM net profit is $35.69 M
What is ANI Pharmaceuticals TTM net income year-on-year change?
Over the past year, ANIP TTM net profit has changed by -$20.47 M (-152.99%)